Teleflex Incorporated

General ticker "TFX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $9.3B (TTM average)

Teleflex Incorporated follows the US Stock Market performance with the rate: 7.1%.

Estimated limits based on current volatility of 1.1%: low 134.85$, high 137.81$

Factors to consider:

  • Earnings expected soon, date: 2025-05-01 bmo
  • Company pays dividends (quarterly): last record date 2025-03-07, amount 0.34$ (Y0.98%)
  • US accounted for 62.0% of revenue in the fiscal year ended 2024-12-31

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [150.57$, 222.45$]
  • 2025-12-31 to 2026-12-31 estimated range: [130.38$, 197.89$]

Financial Metrics affecting the TFX estimates:

  • Positive: Non-GAAP EPS, $ of 14.01 > 2.19
  • Positive: 43.26 < Shareholder equity ratio, % of 60.27 <= 63.75
  • Positive: -0.07 < Operating profit margin, % of 5.18
  • Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of 0.98
  • Negative: Operating cash flow per share per price, % of 7.40 <= 12.73
  • Negative: Interest expense per share, $ of 1.78 > 0.67
  • Negative: negative Industry operating income (median)
  • Positive: -3.20 < Investing cash flow per share, $ of -2.12

Similar symbols

Short-term TFX quotes

2025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-29125130135140
Price $

Long-term TFX plot with estimates

150200250300350400Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202701234
TFXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $2,797.55MM $2,933.69MM $2,914.59MM
Operating Expenses $2,297.82MM $2,427.38MM $2,763.58MM
Operating Income $499.73MM $506.31MM $151.01MM
Non-Operating Income $-53.81MM $-72.30MM $-75.53MM
Interest Expense $54.26MM $85.08MM $83.54MM
R&D Expense $153.82MM $154.35MM $161.67MM
Income(Loss) $445.92MM $434.01MM $75.48MM
Taxes $83.00MM $76.44MM $5.32MM
Other Income(Loss) $0.22MM $-1.24MM $-0.49MM
Profit(Loss)* $363.36MM $355.08MM $69.19MM
Stockholders Equity $4,021.97MM $4,440.99MM $4,278.14MM
Inventory $578.51MM $626.22MM $600.13MM
Assets $6,928.06MM $7,532.55MM $7,097.91MM
Operating Cash Flow $342.14MM $510.64MM $635.74MM
Capital expenditure $79.19MM $91.44MM $126.43MM
Investing Cash Flow $-257.94MM $-621.23MM $-99.36MM
Financing Cash Flow $-217.51MM $38.54MM $-421.93MM
Earnings Per Share** $7.75 $7.56 $1.48

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.